Statins, Zetia reverse atherosclerosis in study - Reuters

NECN

Statins, Zetia reverse atherosclerosis in study Reuters - 21 hours ago Initial results of the Sands study, which compared aggressive lowering of cholesterol and blood pressure with standard lowering, were published in April. ... Aggressive Lipid Lowering Controls Atherosclerosis Effects MedPage Today Study: Anti-cholesterol treatment helps diabetic patients NECN all 8 news articles

Cigna Cuts Cost of Pfizer’s Lipitor as Much as Half (Update2) - Bloomberg

Cigna Cuts Cost of Pfizer’s Lipitor as Much as Half (Update2) Bloomberg - Dec 3, 2008 Cholesterol-lowering drugs are the second most widely prescribed class of medicines in the US, with 221 million prescriptions written last year, ... Lipitor Moves to Preferred Brand Status on CIGNA's Prescription ... MarketWatch Insurer Cigna halves co-pays for cholesterol drug Lipitor Denver Post all 15 news articles

The Top Ten Health Stories of 2008 - HealthNewsDigest.com

The Top Ten Health Stories of 2008 HealthNewsDigest.com, NY - 4 hours ago One showed that in people with a rare inherited condition, Vytorin did a great job lowering cholesterol but didn't reduce atherosclerosis. ...

Merck’s Lower Profit Forecast Disappoints Investors (Update1) - Bloomberg

Post Chronicle

Merck’s Lower Profit Forecast Disappoints Investors (Update1) Bloomberg - 2 hours ago 4 (Bloomberg) -- Merck & Co. said 2009 profit may decline amid falling sales of its Zetia and Vytorin cholesterol pills and weak international revenue. ... Merck 2009 profit outlook misses estimates Houston Chronicle UPDATE: Merck Sees 2009 Profit Below Estimates EasyBourse.com Merck 2009 profit outlook misses estimates Bismarck Tribune all 203 news articles

HEALTH NEWS - Greene County Record

HEALTH NEWS Greene County Record, VA - 23 hours ago Statins primarily lower LDL cholesterol with minimal benefit on HDL. They are usually well tolerated but can cause leg or muscle discomfort and fatigue, ...